EyePoint Pharmaceuticals Announces New Agreement for Expanded Access of DEXYCU® Within One of the Largest Integrated Delivery Systems in the U.S.


You May Also Like

Merus Announces IND Clearance for MCLA-145

MCLA-145 is a full-length human bispecific antibody binding to PD-L1 and CD137 UTRECHT, The ...

Inovio Pharmaceuticals to Report Third Quarter 2016 Financial Results November 9, 2016

PLYMOUTH MEETING, Pa., Oct. 26, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced ...